What is U.S. Bancorp's earnings per share (EPS)?

U.S. Bancorp (USB) reported diluted earnings per share of $4.62 for fiscal year 2025. This represents a 21.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

U.S. Bancorp (USB) Financials

USB

Trailing 12 months to June 30, 2026

Revenue $29.7B +6.7% YoY

Net Income $8.2B +18.4% YoY

EPS (Diluted) $5.02 +19.8% YoY

Operating Cash Flow $12.5B +68.8% YoY

Market Cap $92.8B as of Oct 23, 2026

Price / Sales 3.1x on $29.7B revenue, trailing 12 months to June 30, 2026

Price / Earnings 11.4x on $8.2B net income, trailing 12 months to June 30, 2026

Price / Book 1.4x on $67.4B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the USB SEC filings page.

U.S. Bancorp (USB) reported $29.7B in revenue over the twelve months to Jun 30, 2026, up 6.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI USB FY2025 2026-10-04

U.S. Bancorp’s 2025 rebound came from stronger earnings on a massive, liability-funded balance sheet rather than asset-light economics.

From FY2024 to FY2025, net income rose 20.2% while revenue rose 4.4%, indicating the earnings rebound came more from improved conversion than volume. The margin step-up to 26.4% alongside lower selling, general and administrative expense suggests expense movement did more work than topline expansion.

Liabilities were $626.7B against equity of $65.2B, making the balance sheet predominantly liability-funded. A 1.1% ROA alongside 11.6% ROE shows leverage converting thin asset returns into a double-digit shareholder return, so the two measures should not be read as interchangeable.

Operating cash flow was $8.0B against $7.6B of net income in FY2025, so reported profit was broadly matched by cash that year. In FY2024, operating cash flow was $11.4B against $6.3B of net income; the swing shows bank cash flow is more volatile than earnings, not a simple earnings proxy.

Financial Health Signals

Financial Health Score 43/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of U.S. Bancorp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

U.S. Bancorp earned a return on assets of 1.1% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is up from 0.9% the prior year. Earnings ranks banks on that return over three years, and U.S. Bancorp scores 60/100 among other banks.

Growth

U.S. Bancorp reported revenue of $28.7B in fiscal year 2025, against $27.5B in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and U.S. Bancorp scores 20/100 among other banks.

Capital

U.S. Bancorp funded 9.4% of its assets with shareholders' equity at the end of fiscal year 2025, holding $65.2B of equity against $692.3B of assets. Capital ranks banks on that cushion, and U.S. Bancorp scores 25/100 among other banks.

Efficiency

Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. U.S. Bancorp scores 60/100 on it among other banks.

Credit Quality

Credit Quality measures the money a bank set aside for loans it expects to go bad, against the size of the loan book it set that money aside for. U.S. Bancorp scores 17/100 on it among other banks.

Stability

U.S. Bancorp reported net income of $7.6B in fiscal year 2025, against $6.3B in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and U.S. Bancorp scores 74/100 among other banks.

Piotroski F-Score Partial

6/6

U.S. Bancorp passes 6 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$7.7B

YoY+10.1%

QoQ+5.8%

5Y CAGR+6.0%

10Y CAGR+3.5%

U.S. Bancorp generated $7.7B in revenue in Q2 2026. This represents an increase of 10.1% from the same quarter a year earlier. Against the prior quarter it is up 5.8%.

Net Income

$2.2B

YoY+19.9%

QoQ+11.9%

5Y CAGR+1.9%

10Y CAGR+3.6%

U.S. Bancorp reported $2.2B in net income in Q2 2026. This represents an increase of 19.9% from the same quarter a year earlier. Against the prior quarter it is up 11.9%.

EPS (Diluted)

$1.35

YoY+21.6%

QoQ+14.4%

5Y CAGR+1.1%

10Y CAGR+5.0%

U.S. Bancorp earned $1.35 per diluted share (EPS) in Q2 2026. This represents an increase of 21.6% from the same quarter a year earlier. Against the prior quarter it is up 14.4%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$66.5B

YoY+15.0%

QoQ+37.3%

5Y CAGR+8.3%

U.S. Bancorp held $66.5B in cash as of Q2 2026; no long-term debt figure is on record for that period.

Dividends Per Share

$0.52

YoY+4.0%

QoQ0.0%

5Y CAGR+4.4%

10Y CAGR+7.4%

U.S. Bancorp paid $0.52 per share in dividends in Q2 2026. This represents an increase of 4.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

1.56B

YoY+0.1%

QoQ+0.4%

5Y CAGR+1.0%

10Y CAGR-0.9%

U.S. Bancorp had 1.56B shares outstanding in Q2 2026. This represents an increase of 0.1% from the same quarter a year earlier. Against the prior quarter it is up 0.4%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Net Margin

28.2%

YoY+2.3pp

QoQ+1.5pp

5Y change-6.2pp

10Y change+0.3pp

U.S. Bancorp's net profit margin was 28.2% in Q2 2026, showing the share of revenue converted to profit. This is up 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Return on Equity

3.2%

YoY+0.3pp

QoQ+0.3pp

5Y change-0.5pp

10Y change0.0pp

U.S. Bancorp's quarterly ROE was 3.2% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$201.0M

YoY+89.6%

QoQ-27.2%

5Y CAGR-25.8%

10Y CAGR-11.7%

U.S. Bancorp spent $201.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 89.6% from the same quarter a year earlier. Against the prior quarter it is down 27.2%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

USB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

USB quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$29.7B	$28.7B+4.4%	$27.5B-2.4%	$28.1B+15.8%	$24.3B+7.0%	$22.7B-2.2%	$23.2B+1.5%	$22.9B+1.1%	$22.6B+3.4%	$21.9B+2.8%	$21.3B+4.9%	$20.3B+0.7%	$20.2B+2.9%	$19.6B-3.4%	$20.3B+7.4%	$18.9B
Interest Expense	$14.2B	$14.3B-6.9%	$15.4B+21.9%	$12.6B+292.0%	$3.2B+224.0%	$993.0M-50.7%	$2.0B-54.6%	$4.4B+36.5%	$3.3B+65.5%	$2.0B+33.9%	$1.5B+4.8%	$1.4B-3.6%	$1.5B-13.6%	$1.7B-21.4%	$2.1B-15.0%	$2.5B
Income Tax	$2.0B	$1.9B+21.6%	$1.6B+12.3%	$1.4B-3.8%	$1.5B-32.9%	$2.2B+104.6%	$1.1B-35.3%	$1.6B+6.0%	$1.6B+22.9%	$1.3B-41.5%	$2.2B+3.1%	$2.1B+0.5%	$2.1B+2.7%	$2.0B-9.1%	$2.2B+21.5%	$1.8B
Net Income	$8.2B	$7.6B+20.2%	$6.3B+16.0%	$5.4B-6.8%	$5.8B-26.8%	$8.0B+60.6%	$5.0B-28.3%	$6.9B-2.6%	$7.1B+14.1%	$6.2B+5.6%	$5.9B+0.2%	$5.9B+0.5%	$5.9B+0.3%	$5.8B+3.3%	$5.6B+15.9%	$4.9B
EPS (Basic)	N/A	$4.62+21.9%	$3.79+15.9%	$3.27-11.4%	$3.69-27.8%	$5.11+67.0%	$3.06-26.4%	$4.16+0.2%	$4.15+17.6%	$3.53+8.6%	$3.25+2.2%	$3.18+2.6%	$3.10+2.6%	$3.02+6.0%	$2.85+15.4%	$2.47
EPS (Diluted)	$5.02	$4.62+21.9%	$3.79+15.9%	$3.27-11.4%	$3.69-27.6%	$5.10+66.7%	$3.06-26.4%	$4.16+0.5%	$4.14+17.9%	$3.51+8.3%	$3.24+2.5%	$3.16+2.6%	$3.08+2.7%	$3.00+5.6%	$2.84+15.4%	$2.46
Diluted Shares (Avg)	N/A	1.56B-0.2%	1.56B+1.2%	1.54B+3.6%	1.49B0.0%	1.49B-1.3%	1.51B-4.6%	1.58B-3.4%	1.64B-2.7%	1.68B-2.4%	1.72B-2.7%	1.77B-2.3%	1.81B-1.9%	1.85B-2.5%	1.90B-1.4%	1.92B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$7.7B+10.1%	$7.3B+4.7%	$7.4B+5.1%	$7.3B+6.8%	$7.0B+2.0%	$7.0B+3.6%	$7.0B+3.7%	$6.9B-2.4%
Interest Expense	$3.2B-8.9%	$3.6B+4.4%	$3.6B-1.2%	$3.7B-6.2%	$3.6B-10.3%	$3.4B-9.4%	$3.7B+0.9%	$4.0B+12.3%
Income Tax	$537.0M+13.8%	$469.0M+5.9%	$482.0M+10.0%	$524.0M+49.7%	$472.0M+6.1%	$443.0M+27.7%	$438.0M+215.1%	$350.0M-18.8%
Net Income	$2.2B+19.9%	$1.9B+13.8%	$2.0B+23.0%	$2.0B+16.7%	$1.8B+13.2%	$1.7B+29.6%	$1.7B+96.3%	$1.7B+12.5%
EPS (Basic)	$1.35+21.6%	$1.18+14.6%	$1.26+23.5%	$1.22+18.4%	$1.11+14.4%	$1.03+32.1%	$1.02+112.5%	$1.03+13.2%
EPS (Diluted)	$1.35+21.6%	$1.18+14.6%	$1.27+24.5%	$1.22+18.4%	$1.11+14.4%	$1.03+32.1%	$1.02+112.5%	$1.03+13.2%
Diluted Shares (Avg)	1.55B-0.3%	1.55B-0.3%	N/A	1.56B-0.3%	1.56B-0.1%	1.56B+0.1%	N/A	1.56B+0.8%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

USB Balance Sheet

USB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$692.3B+2.1%	$678.3B+2.2%	$663.5B-1.7%	$674.8B+17.7%	$573.3B+3.5%	$553.9B+11.8%	$495.4B+6.0%	$467.4B+1.2%	$462.0B+3.6%	$446.0B+5.7%	$421.9B+4.8%	$402.5B+10.6%	$364.0B+2.9%	$353.9B+4.0%	$340.1B
Cash & Equivalents	$46.9B-17.0%	$56.5B-7.7%	$61.2B+14.3%	$53.5B+85.2%	$28.9B-53.8%	$62.6B+179.3%	$22.4B	N/A	N/A	N/A	N/A	N/A	N/A	$8.3B-40.9%	$14.0B
Goodwill	$12.6B+0.8%	$12.5B+0.4%	$12.5B+0.9%	$12.4B+20.6%	$10.3B+3.5%	$9.9B+2.7%	$9.7B+3.1%	$9.4B-0.7%	$9.4B+1.0%	$9.3B-0.2%	$9.4B-0.3%	$9.4B+2.0%	$9.2B+0.7%	$9.1B+2.4%	$8.9B
Total Liabilities	$626.7B+1.2%	$619.3B+1.9%	$607.7B-2.5%	$623.6B+20.4%	$517.9B+3.5%	$500.2B+12.9%	$442.9B+6.5%	$415.7B+0.8%	$412.4B+3.6%	$398.0B+6.1%	$375.0B+4.7%	$358.4B+11.2%	$322.2B+2.8%	$313.6B+2.8%	$305.2B
Long-Term Debt	N/A	N/A	N/A	$39.8B+24.0%	$32.1B-22.2%	$41.3B+2.8%	$40.2B-2.8%	$41.3B+28.2%	$32.3B-3.2%	$33.3B+3.9%	$32.1B-0.6%	$32.3B+60.9%	$20.0B-21.4%	$25.5B-20.1%	$32.0B
Total Equity	$65.2B+11.3%	$58.6B+5.9%	$55.3B+8.9%	$50.8B-7.6%	$54.9B+3.4%	$53.1B+2.4%	$51.9B+1.6%	$51.0B+4.1%	$49.0B+3.7%	$47.3B+2.5%	$46.1B+6.1%	$43.5B+5.8%	$41.1B+5.4%	$39.0B+14.8%	$34.0B
Retained Earnings	$80.9B+5.3%	$76.9B+3.8%	$74.0B+3.0%	$71.9B+3.9%	$69.2B+7.8%	$64.2B+1.6%	$63.2B+7.0%	$59.1B+9.1%	$54.1B+8.0%	$50.2B+8.1%	$46.4B+9.0%	$42.5B+10.0%	$38.7B+11.4%	$34.7B+12.8%	$30.8B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$725.9B+5.8%	$701.0B+3.6%	$692.3B+2.1%	$695.4B+1.3%	$686.4B+0.9%	$676.5B-1.0%	$678.3B+2.2%	$686.5B+2.8%
Cash & Equivalents	$66.5B+15.0%	$48.4B-3.2%	$46.9B-17.0%	$66.6B-9.4%	$57.8B-12.2%	$50.0B-35.0%	$56.5B-7.7%	$73.6B+14.3%
Goodwill	$13.2B+4.7%	$12.6B+0.6%	$12.6B+0.8%	$12.6B+0.5%	$12.6B+1.3%	$12.6B+0.6%	$12.5B+0.4%	$12.6B+0.8%
Total Liabilities	$658.0B+5.4%	$634.8B+3.1%	$626.7B+1.2%	$631.6B+0.7%	$624.5B+0.2%	$615.9B-1.9%	$619.3B+1.9%	$627.1B+2.1%
Total Equity	$67.4B+9.8%	$65.8B+9.5%	$65.2B+11.3%	$63.3B+7.6%	$61.4B+8.9%	$60.1B+8.1%	$58.6B+5.9%	$58.9B+10.8%
Retained Earnings	$83.2B+5.8%	$81.9B+5.5%	$80.9B+5.3%	$79.7B+4.8%	$78.7B+4.5%	$77.7B+4.3%	$76.9B+3.8%	$76.1B+2.7%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

USB Cash Flow Statement

USB quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$12.5B	$8.0B-29.8%	$11.3B+35.2%	$8.4B-60.3%	$21.1B+114.0%	$9.9B+165.6%	$3.7B-24.0%	$4.9B-53.7%	$10.6B+63.2%	$6.5B+21.3%	$5.3B-39.2%	$8.8B+64.7%	$5.3B-53.4%	$11.4B+43.8%	$8.0B-19.0%	$9.8B
Stock-Based Compensation	N/A	$235.0M+1.3%	$232.0M+3.6%	$224.0M+10.9%	$202.0M-2.4%	$207.0M+9.5%	$189.0M+6.2%	$178.0M+2.3%	$174.0M+6.7%	$163.0M+8.7%	$150.0M+20.0%	$125.0M0.0%	$125.0M-3.1%	$129.0M0.0%	$129.0M+9.3%	$118.0M
Investing Cash Flow	-$28.3B	-$20.5Bn/m	-$24.5B-229.6%	$18.9B+152.3%	$7.5Bn/m	-$57.5Bn/m	-$15.4Bn/m	-$21.6Bn/m	-$9.0Bn/m	-$12.1Bn/m	-$18.0B	N/A	N/A	N/A	-$20.3Bn/m	-$32.7B
Financing Cash Flow	$24.7B	$2.3B-74.5%	$8.8Bn/m	-$20.0Bn/m	-$4.0B-128.6%	$13.9B-73.1%	$51.9B+194.5%	$17.6B+4781.7%	$361.0M-96.2%	$9.5B-45.0%	$17.2B	N/A	N/A	N/A	$6.6B-70.5%	$22.4B
Dividends Paid	$3.2B	$3.2B+2.5%	$3.1B+4.1%	$3.0B+7.0%	$2.8B+7.6%	$2.6B+1.1%	$2.6B+4.5%	$2.4B+16.8%	$2.1B+8.5%	$1.9B+6.5%	$1.8B+1.9%	$1.8B+3.0%	$1.7B+9.5%	$1.6B+17.0%	$1.3B+64.9%	$817.0M
Share Buybacks	$700.0M	$489.0M+182.7%	$173.0M+179.0%	$62.0M-10.1%	$69.0M-95.6%	$1.6B-7.0%	$1.7B-63.0%	$4.5B+60.3%	$2.8B+7.3%	$2.6B+2.9%	$2.6B+16.7%	$2.2B-0.5%	$2.2B-3.6%	$2.3B+23.0%	$1.9B+261.1%	$514.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$4.8B+152.0%	$1.3Bn/m	$2.8B-41.4%	$3.5B+263.1%	$1.9B-33.4%	-$308.0M-111.6%	$4.8B+1237.8%	$972.0M-74.9%
Investing Cash Flow	-$6.4Bn/m	-$5.4Bn/m	-$16.9Bn/m	$230.0M-85.8%	-$1.4Bn/m	-$2.5Bn/m	-$12.9B-815.3%	$1.6B-71.2%
Financing Cash Flow	$19.7B+191.1%	$5.7Bn/m	-$6.4Bn/m	$5.8B+13.3%	$6.8Bn/m	-$3.9B-121.5%	-$8.7Bn/m	$5.1Bn/m
Dividends Paid	$812.0M+3.6%	$816.0M+3.7%	$813.0M+3.6%	$784.0M+2.1%	$784.0M+2.0%	$787.0M+2.2%	$785.0M+4.5%	$768.0M+3.8%
Share Buybacks	$201.0M+89.6%	$276.0M+72.5%	$122.0M0.0%	$101.0M+10000.0%	$106.0M+10500.0%	$160.0M+226.5%	$122.0M+617.6%	$1.0M0.0%

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow.

USB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

USB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	26.4%+3.5pp	22.9%+3.7pp	19.3%-4.7pp	24.0%-11.1pp	35.0%+13.7pp	21.3%-8.9pp	30.2%-1.1pp	31.4%+3.0pp	28.4%+0.8pp	27.6%-1.3pp	28.9%-0.1pp	29.0%-0.8pp	29.8%+1.9pp	27.8%+2.0pp	25.8%
Return on Equity	11.6%+0.9pp	10.8%+0.9pp	9.8%-1.7pp	11.5%-3.0pp	14.5%+5.2pp	9.3%-4.0pp	13.3%-0.6pp	13.9%+1.2pp	12.7%+0.2pp	12.4%-0.3pp	12.7%-0.7pp	13.5%-0.7pp	14.2%-0.3pp	14.5%+0.1pp	14.3%
Return on Assets	1.1%+0.2pp	0.9%+0.1pp	0.8%0.0pp	0.9%-0.5pp	1.4%+0.5pp	0.9%-0.5pp	1.4%-0.1pp	1.5%+0.2pp	1.4%0.0pp	1.3%-0.1pp	1.4%-0.1pp	1.5%-0.1pp	1.6%0.0pp	1.6%+0.2pp	1.4%
Debt-to-Equity	N/A	N/A	N/A	0.78+0.2x	0.58-0.2x	0.780.0x	0.770.0x	0.81+0.2x	0.660.0x	0.700.0x	0.700.0x	0.74+0.3x	0.49-0.2x	0.65-0.3x	0.94
Liabilities-to-Equity	9.61-1.0x	10.57-0.4x	10.99-1.3x	12.28+2.9x	9.430.0x	9.42+0.9x	8.54+0.4x	8.15-0.3x	8.410.0x	8.42+0.3x	8.13-0.1x	8.24+0.4x	7.84-0.2x	8.04-0.9x	8.98
Asset Turnover	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.060.0x	0.06

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	28.2%+2.3pp	26.7%+2.1pp	27.8%+4.0pp	27.3%+2.3pp	25.9%+2.6pp	24.6%+4.9pp	23.7%+11.2pp	25.0%+3.3pp
Return on Equity	3.2%+0.3pp	3.0%+0.1pp	3.1%+0.3pp	3.2%+0.3pp	2.9%+0.1pp	2.8%+0.5pp	2.8%+1.3pp	2.9%0.0pp
Return on Assets	0.3%0.0pp	0.3%0.0pp	0.3%+0.1pp	0.3%0.0pp	0.3%0.0pp	0.3%+0.1pp	0.3%+0.1pp	0.3%0.0pp
Liabilities-to-Equity	9.76-0.4x	9.65-0.6x	9.61-1.0x	9.97-0.7x	10.16-0.9x	10.25-1.0x	10.57-0.4x	10.66-0.9x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
U.S. Bancorp USB	FY2025	$28.7B	$7.6B	26.4%	$92.8B	43/100
PNC Financial Services Group PNC	FY2025	$23.1B	$6.9B	30.0%	$90.0B	58/100
Nu Holdings Ltd. NU	FY2025	$15.8B	$2.9B	18.2%	$71.2B	71/100
Deutsche Bank AG DB	FY2025	$36.9B	N/A	N/A	$59.2B	25/100
Truist Financial Corporation TFC	FY2025	$20.3B	$5.3B	26.1%	$59.2B	30/100

Where U.S. Bancorp Ranks

Frequently Asked Questions

What is U.S. Bancorp's annual revenue?

U.S. Bancorp (USB) reported $28.7B in total revenue for fiscal year 2025. This represents a 4.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is U.S. Bancorp's revenue growing?

U.S. Bancorp (USB) revenue grew by 4.4% year-over-year, from $27.5B to $28.7B in fiscal year 2025.

Is U.S. Bancorp profitable?

Yes, U.S. Bancorp (USB) reported a net income of $8.2B over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $7.6B, with a net profit margin of 26.4%.

What is U.S. Bancorp's net profit margin?

U.S. Bancorp (USB) had a net profit margin of 26.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does U.S. Bancorp pay dividends?

Yes, U.S. Bancorp (USB) paid $2.04 per share in dividends during fiscal year 2025.

What is U.S. Bancorp's return on equity (ROE)?

U.S. Bancorp (USB) has a return on equity of 11.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is U.S. Bancorp's operating cash flow?

U.S. Bancorp (USB) generated $8.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are U.S. Bancorp's total assets?

U.S. Bancorp (USB) had $692.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Does U.S. Bancorp buy back shares?

Yes, U.S. Bancorp (USB) spent $489.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does U.S. Bancorp have outstanding?

U.S. Bancorp (USB) had 1.55B shares outstanding as of fiscal year 2025.

What is U.S. Bancorp's liabilities-to-equity ratio?

U.S. Bancorp (USB) had a liabilities-to-equity ratio of 9.61 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

What is U.S. Bancorp's return on assets (ROA)?

U.S. Bancorp (USB) had a return on assets of 1.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is U.S. Bancorp's P/E ratio?

U.S. Bancorp (USB) trades at 11.4x earnings, its market capitalization divided by $8.2B net income, trailing 12 months to June 30, 2026. The market capitalization is $92.8B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is U.S. Bancorp's price-to-sales ratio?

U.S. Bancorp (USB) trades at 3.1x sales, its market capitalization divided by $29.7B revenue, trailing 12 months to June 30, 2026. The market capitalization is $92.8B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is U.S. Bancorp's Piotroski F-Score?

U.S. Bancorp (USB) has a Piotroski F-Score of 6 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

How financially healthy is U.S. Bancorp?

U.S. Bancorp (USB) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is the average of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.